Viridian Therapeutics, Inc.\DE (VRDN) Receivables (2013 - 2021)
Viridian Therapeutics, Inc.\DE (VRDN) reported Receivables of $1.48 million for Q3 2021, compared with $57,000 a year earlier.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Receivables (2013 - 2021) Analysis & Trends
At the end of FY2019, Viridian Therapeutics, Inc.\DE posted Receivables of $108,000, up 350.0% from FY2018.
- Receivables has a five-year compound annual growth rate of -37.0% (FY2014 to FY2019).
- By year, Receivables came in at $24,000 in FY2018 (-99.1%), $2.56 million in FY2017 (+698.8%), $320,000 in FY2016 (-18.8%) and $394,000 in FY2015 (-63.8%).
- The Q3 2021 figure ranks as the highest quarterly Receivables since Q1 2018.
- Year over year, Receivables gained in 1 of the last four quarters, with growth averaging 49.7%.
- The high point for year-over-year Receivables in five years was Q4 2017 (growth of 698.8%); the low point was Q1 2019 (a decline of 99.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 1.48 Mn |
| Sep 30, 2020 | 57,000.00 |
| Jun 30, 2020 | 248,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 108,000.00 |
| Sep 30, 2019 | 979,000.00 |
| Jun 30, 2019 | 325,000.00 |
| Mar 31, 2019 | 6,000.00 |
| Dec 31, 2018 | 24,000.00 |
| Sep 30, 2018 | 1.38 Mn |
| Jun 30, 2018 | 1.20 Mn |
| Mar 31, 2018 | 5.76 Mn |
| Dec 31, 2017 | 2.56 Mn |
| Sep 30, 2017 | 2.07 Mn |
| Jun 30, 2017 | 1.01 Mn |
| Mar 31, 2017 | 277,000.00 |
| Dec 31, 2016 | 320,000.00 |
| Sep 30, 2016 | 733,000.00 |
| Jun 30, 2016 | 658,000.00 |
| Mar 31, 2016 | 490,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();